Utah Retirement Systems’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-42,099
Closed -$7.73M 1008
2021
Q2
$7.73M Buy
42,099
+1,300
+3% +$223K 0.1% 203
2021
Q1
$6.24M Sell
40,799
-1,800
-4% -$278K 0.09% 232
2020
Q4
$6.66M Buy
42,599
+1,800
+4% +$231K 0.09% 214
2020
Q3
$4.67M Buy
40,799
+300
+0.7% +$32.4K 0.08% 254
2020
Q2
$4.54M Sell
40,499
-100
-0.2% -$10.6K 0.08% 240
2020
Q1
$3.65M Hold
40,599
0.08% 237
2019
Q4
$4.39M Sell
40,599
-400
-1% -$42.8K 0.08% 257
2019
Q3
$4.01M Buy
40,999
+300
+0.7% +$33.8K 0.08% 263
2019
Q2
$5.33M Buy
40,699
+273
+0.7% +$35.2K 0.1% 203
2019
Q1
$5.46M Buy
40,426
+523
+1% +$65K 0.11% 192
2018
Q4
$3.88M Buy
39,903
+100
+0.3% +$11.8K 0.09% 227
2018
Q3
$5.53M Buy
39,803
+200
+0.5% +$25.1K 0.11% 195
2018
Q2
$4.92M Sell
39,603
-500
-1% -$58.4K 0.1% 205
2018
Q1
$4.47M Sell
40,103
-400
-1% -$47.8K 0.1% 220
2017
Q4
$4.84M Buy
40,503
+500
+1% +$60.9K 0.1% 210
2017
Q3
$5.61M Buy
40,003
+100
+0.3% +$13.6K 0.13% 177
2017
Q2
$4.86M Buy
39,903
+200
+0.5% +$23.3K 0.11% 193
2017
Q1
$4.81M Hold
39,703
0.12% 194
2016
Q4
$4.86M Sell
39,703
-100
-0.3% -$12.2K 0.12% 183
2016
Q3
$4.88M Hold
39,803
0.13% 177
2016
Q2
$4.65M Buy
39,803
+1,000
+3% +$142K 0.12% 178
2016
Q1
$5.4M Buy
38,803
+100
+0.3% +$14.7K 0.15% 148
2015
Q4
$7.38M Hold
38,703
0.2% 108
2015
Q3
$6.05M Buy
38,703
+200
+0.5% +$36.5K 0.17% 125
2015
Q2
$6.96M Buy
38,503
+3,061
+9% +$528K 0.19% 119
2015
Q1
$6.14M Buy
35,442
+1,100
+3% +$199K 0.16% 136
2014
Q4
$6.35M Hold
34,342
0.17% 124
2014
Q3
$5.69M Sell
34,342
-100
-0.3% -$16.4K 0.16% 133
2014
Q2
$5.38M Sell
34,442
-600
-2% -$94.7K 0.15% 143
2014
Q1
$5.33M Buy
35,042
+300
+0.9% +$47.7K 0.15% 141
2013
Q4
$4.62M Hold
34,742
0.14% 159
2013
Q3
$4.04M Sell
34,742
-300
-0.9% -$32.9K 0.13% 169
2013
Q2
$3.23M Buy
+35,042
New +$3.38M 0.11% 199

Other funds holding ALXN